IBDEI0NV ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11689,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,11689,1,5,0)
 ;;=5^Diabetes, Type 1
 ;;^UTILITY(U,$J,358.3,11689,2)
 ;;=^331780
 ;;^UTILITY(U,$J,358.3,11690,0)
 ;;=250.00^^64^703^27
 ;;^UTILITY(U,$J,358.3,11690,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11690,1,4,0)
 ;;=4^250.00
 ;;^UTILITY(U,$J,358.3,11690,1,5,0)
 ;;=5^Diabetes, Type 2
 ;;^UTILITY(U,$J,358.3,11690,2)
 ;;=^331779
 ;;^UTILITY(U,$J,358.3,11691,0)
 ;;=305.90^^64^703^29
 ;;^UTILITY(U,$J,358.3,11691,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11691,1,4,0)
 ;;=4^305.90
 ;;^UTILITY(U,$J,358.3,11691,1,5,0)
 ;;=5^Drug Abuse-Unspec
 ;;^UTILITY(U,$J,358.3,11691,2)
 ;;=^268258
 ;;^UTILITY(U,$J,358.3,11692,0)
 ;;=305.93^^64^703^28
 ;;^UTILITY(U,$J,358.3,11692,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11692,1,4,0)
 ;;=4^305.93
 ;;^UTILITY(U,$J,358.3,11692,1,5,0)
 ;;=5^Drug Abuse-In Remission
 ;;^UTILITY(U,$J,358.3,11692,2)
 ;;=^268261
 ;;^UTILITY(U,$J,358.3,11693,0)
 ;;=796.2^^64^703^33
 ;;^UTILITY(U,$J,358.3,11693,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11693,1,4,0)
 ;;=4^796.2
 ;;^UTILITY(U,$J,358.3,11693,1,5,0)
 ;;=5^Elevated BP w/o HTN
 ;;^UTILITY(U,$J,358.3,11693,2)
 ;;=^273464
 ;;^UTILITY(U,$J,358.3,11694,0)
 ;;=607.84^^64^703^35
 ;;^UTILITY(U,$J,358.3,11694,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11694,1,4,0)
 ;;=4^607.84
 ;;^UTILITY(U,$J,358.3,11694,1,5,0)
 ;;=5^Erectile Dysfunction
 ;;^UTILITY(U,$J,358.3,11694,2)
 ;;=^270441
 ;;^UTILITY(U,$J,358.3,11695,0)
 ;;=530.81^^64^703^36
 ;;^UTILITY(U,$J,358.3,11695,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11695,1,4,0)
 ;;=4^530.81
 ;;^UTILITY(U,$J,358.3,11695,1,5,0)
 ;;=5^GERD
 ;;^UTILITY(U,$J,358.3,11695,2)
 ;;=^295749
 ;;^UTILITY(U,$J,358.3,11696,0)
 ;;=389.9^^64^703^39
 ;;^UTILITY(U,$J,358.3,11696,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11696,1,4,0)
 ;;=4^389.9
 ;;^UTILITY(U,$J,358.3,11696,1,5,0)
 ;;=5^Hearing Loss NOS
 ;;^UTILITY(U,$J,358.3,11696,2)
 ;;=^54552
 ;;^UTILITY(U,$J,358.3,11697,0)
 ;;=784.0^^64^703^38
 ;;^UTILITY(U,$J,358.3,11697,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11697,1,4,0)
 ;;=4^784.0
 ;;^UTILITY(U,$J,358.3,11697,1,5,0)
 ;;=5^Headaches
 ;;^UTILITY(U,$J,358.3,11697,2)
 ;;=^54133
 ;;^UTILITY(U,$J,358.3,11698,0)
 ;;=070.54^^64^703^40
 ;;^UTILITY(U,$J,358.3,11698,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11698,1,4,0)
 ;;=4^070.54
 ;;^UTILITY(U,$J,358.3,11698,1,5,0)
 ;;=5^Hepatitis C
 ;;^UTILITY(U,$J,358.3,11698,2)
 ;;=^303252
 ;;^UTILITY(U,$J,358.3,11699,0)
 ;;=272.4^^64^703^41
 ;;^UTILITY(U,$J,358.3,11699,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11699,1,4,0)
 ;;=4^272.4
 ;;^UTILITY(U,$J,358.3,11699,1,5,0)
 ;;=5^Hyperlipidemia
 ;;^UTILITY(U,$J,358.3,11699,2)
 ;;=^87281
 ;;^UTILITY(U,$J,358.3,11700,0)
 ;;=272.2^^64^703^42
 ;;^UTILITY(U,$J,358.3,11700,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11700,1,4,0)
 ;;=4^272.2
 ;;^UTILITY(U,$J,358.3,11700,1,5,0)
 ;;=5^Hyperlipidemia,Mixed
 ;;^UTILITY(U,$J,358.3,11700,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,11701,0)
 ;;=401.9^^64^703^43
 ;;^UTILITY(U,$J,358.3,11701,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11701,1,4,0)
 ;;=4^401.9
 ;;^UTILITY(U,$J,358.3,11701,1,5,0)
 ;;=5^Hypertension NOS
 ;;^UTILITY(U,$J,358.3,11701,2)
 ;;=^186630
 ;;^UTILITY(U,$J,358.3,11702,0)
 ;;=244.9^^64^703^44
 ;;^UTILITY(U,$J,358.3,11702,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11702,1,4,0)
 ;;=4^244.9
 ;;^UTILITY(U,$J,358.3,11702,1,5,0)
 ;;=5^Hypothyroidism NOS
 ;;^UTILITY(U,$J,358.3,11702,2)
 ;;=^123752
 ;;^UTILITY(U,$J,358.3,11703,0)
 ;;=790.21^^64^703^45
 ;;^UTILITY(U,$J,358.3,11703,1,0)
 ;;=^358.31IA^5^2
